BlueStem Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Sell
340
-9
-3% -$9.2K 0.04% 91
2026
Q1
$321K Buy
349
+24
+7% +$24.3K 0.04% 102
2025
Q4
$349K Buy
325
+23
+8% +$22K 0.04% 91
2025
Q3
$230K Buy
+302
New +$225K 0.03% 112

Other funds holding LLY

BlueStem Wealth Partners's LLY Position: Q2 2026 in Review

BlueStem Wealth Partners reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $9.2K and leaving 340 shares worth $408K. The position accounts for 0.04% of the portfolio, ranked #91.

BlueStem Wealth Partners first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BlueStem Wealth Partners held 340 shares of Eli Lilly worth $408K as of Q2 2026.
  • BlueStem Wealth Partners sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.04% of BlueStem Wealth Partners's portfolio in Q2 2026, its #91 holding.
  • BlueStem Wealth Partners first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BlueStem Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.